1. Introduction Hypertrophic cardiomyopathy (HCM) is a primary myocardial genetic disorder characterised by myocardial hypertrophy. Hypertrophy can be described as the structural, functional, and electrical remodelling of the myocardium. The global prevalence of HCM oscillates around 1:500 (0.2%), thus affecting approximately 894,000 patients in Europe, and 75,500 in Poland [1,2].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Daniel
Contact Daniel, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack